Comparison between PET and PET/CT in recurrent head and neck cancer and clinical implications

[1]  C. Snyderman,et al.  Head and neck malignancy: is PET/CT more accurate than PET or CT alone? , 2005, Radiology.

[2]  D. Visvikis,et al.  Impact of combined 18F-FDG PET/CT in head and neck tumours , 2005, British Journal of Cancer.

[3]  Yuji Nakamoto,et al.  Normal FDG distribution patterns in the head and neck: PET/CT evaluation. , 2005, Radiology.

[4]  C. Meltzer,et al.  The use of Combined PET/CT for Localizing Recurrent Head and Neck Cancer: The Pittsburgh Experience , 2005, Ear, nose, & throat journal.

[5]  J. Debatin,et al.  Unknown primary tumors: detection with dual-modality PET/CT--initial experience. , 2005, Radiology.

[6]  Mithat Gonen,et al.  Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. , 2004, Radiology.

[7]  O. Hoekstra,et al.  Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement , 2004, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[8]  T. Whiteside,et al.  Detection of recurrent oral squamous cell carcinoma by [18F]‐2‐fluorodeoxyglucose‐positron emission tomography , 2003, Cancer.

[9]  Carolyn Cidis Meltzer,et al.  PET/CT imaging in recurrent head and neck cancer. , 2003, Seminars in ultrasound, CT, and MR.

[10]  Richard L Wahl,et al.  Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  Mithat Gonen,et al.  Diagnostic and Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomography for Recurrent Head and Neck Squamous Cell Carcinoma , 2002 .

[12]  P. V. van Rijk,et al.  F‐18‐fluoro‐deoxy‐glucose positron‐emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer , 2001, Head & neck.

[13]  F. Hilgers,et al.  Pain as sign of recurrent disease in head and neck squamous cell carcinoma , 2001, Head & neck.

[14]  M. Remacle,et al.  Positron Emission Tomography With Fluorodeoxyglucose for Suspected Head and Neck Tumor Recurrence in the Symptomatic Patient , 2000, The Laryngoscope.

[15]  Paul Kinahan,et al.  A combined PET/CT scanner for clinical oncology. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  W. Goodwin.  Salvage Surgery for Patients With Recurrent Squamous Cell Carcinoma of the Upper Aerodigestive Tract: When Do the Ends Justify the Means? , 2000, The Laryngoscope.

[17]  P. V. van Rijk,et al.  The detection of local recurrent head and neck cancer with fluroine-18 fluorodeoxyglucose dual-head positron emission tomography , 1999, European Journal of Nuclear Medicine.

[18]  A. Alavi,et al.  Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2‐18f‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography , 1999, The Laryngoscope.

[19]  K. Greven,et al.  Laryngeal Radionecrosis versus Recurrent Cancer: A Clinical Approach , 1998, The Annals of otology, rhinology, and laryngology.

[20]  J. Keyes.  SUV: standard uptake or silly useless value? , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  J. Hoffman,et al.  Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy , 1994, Head & neck.

[22]  P. Hudgins,et al.  Imaging modalities in recurrent head and neck tumors , 1991, The Laryngoscope.

[23]  S. Taylor.  Head and neck cancer. , 1991, Cancer chemotherapy and biological response modifiers.